The Adenosine-Pathway Targeted Cancer Immunotherapy Summit unites a highly focused community of experts working to support the collective mission of supercharging adenosine-pathway therapies to patients in need.
Showcase how your company enables drug developers to overcome the barriers to developing truly curative Adenosine Targeted Immunotherapies, such as tumor models, immunoassays, diagnostics and biomarkers, and CRO. Whether this is through speaking on the agenda, hosting networking sessions or exhibiting, we’ll work with you to build a bespoke partnership to ensure that you meet your 2022 business objectives.
Address the field’s current unmet needs an hear how and where pharmaceutical giants are looking for services and solutions to facilitate their R&D platforms
Meet & Network with Industry Pioneers
Meet prospective clients during structured networking breaks, bespoke 1-2-1 meetings and more informal networking receptions
Position Yourself as an Industry Expert
Showcase your independent expertise in front of the key decision-makers in the field including biotech companies focused on developing adenosine inhibitors, large pharma and investors
Raise your Brand Awareness
Benefit from post-conference exposure to our KOL community and increase market share through unique branding formats
Generate Commercial Collaborations
Ensure your hottest prospects are in the room and part of the discussion by having a wish-list of your choice contacted in advance of the event